面肩肱型肌营养不良1型的基于家族的外显率研究
在一家国家级面肩肱型肌营养不良(FSHD)专病中心开展观察性横断面研究,纳入10例携带4-9个D4Z4单元等位基因的FSHD1先证者及140名亲属,共150人进行遗传学检测(含突变携带者D4Z4甲基化水平)。症状性及症状性加无症状的FSHD最大似然估计显示外显率取决于重复片段大小并随年龄增长至成年晚期;观察到许多无症状携带者(25% [17/69])有轻微面部无力伴或不伴轻度肩带无力,非外显率低于近期人群研究(17% [12/69])。
要点
- 外显率取决于D4Z4重复片段大小,并随年龄增长至成年晚期。
- 无症状携带者占25%(17/69),多表现为轻微面部无力伴或不伴轻度肩带无力。
- 非外显率为17%(12/69),低于近期人群研究;多数无症状患者报告有肩痛。
核心结论
- 本家族研究检测到的总体非外显率低于既往观察,可能由于仔细检查面部和肩部肌肉识别出许多无症状突变携带者。
- 识别无症状突变携带者对将来试验的受试者选择至关重要,且似然估计有助于遗传咨询。
研究设计与样本
- 在一家国家级FSHD专病中心开展的观察性横断面研究。
- 纳入10例携带4-9个D4Z4单元等位基因的FSHD1先证者及140名亲属,共150名参与者进行遗传学检测,包括突变携带者的D4Z4甲基化水平。
- 突变携带者分为:症状性(有肌无力病史且检查有FSHD肌肉体征)、无症状(无肌无力病史但检查有FSHD肌肉体征)、非外显(无肌无力病史且检查无FSHD肌肉体征)。
- 评估年龄校正临床严重度评分与重复片段大小、性别及D4Z4甲基化水平的关系。
主要发现
- 症状性及症状性加无症状FSHD的最大似然估计显示外显率取决于重复片段大小,并随年龄增长至成年晚期。
- 观察到许多无症状携带者(25% [17/69])有轻微面部无力伴或不伴轻度肩带无力。
- 非外显率低于近期人群研究(17% [12/69]),且多数无症状患者报告有肩痛。
- D4Z4甲基化在7或9个重复片段的中重度受累突变携带者中倾向较低。
临床怎么用
- 作者认为识别无症状突变携带者对将来试验的受试者选择至关重要,似然估计有助于遗传咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: An observational cross-sectional study was conducted in a national facioscapulohumeral muscular dystrophy (FSHD) expertise center to estimate the penetrance of FSHD1 and to evaluate phenotype-genotype correlations. METHODS: Ten FSHD1 probands carrying 4-9 D4Z4 unit alleles and 140 relatives were examined. All 150 participants were genetically characterized, including D4Z4 methylation levels in the mutation carriers. Mutation carriers were classified as (1) symptomatic: with symptoms of muscle weakness on history and muscle FSHD signs on examination; (2) asymptomatic: without symptoms of muscle weakness but with muscle FSHD signs on examination; and (3) nonpenetrant: without symptoms of muscle weakness on history and without muscle FSHD signs on examination. We assessed the relationship between age-corrected clinical severity score and repeat size, sex, and D4Z4 methylation levels. RESULTS: The maximum likelihood estimates of symptomatic and those of symptomatic plus asymptomatic FSHD showed that penetrance depends on repeat size and increases until late adulthood. We observed many asymptomatic carriers with subtle facial weakness with or without mild shoulder girdle weakness (25% [17/69]). Nonpenetrance was observed less frequently than in recent population studies (17% [12/69]), and most asymptomatic patients reported some shoulder pain. D4Z4 methylation tended to be lower in moderately to severely affected mutation carriers with 7 or 9 repeats. DISCUSSION: This family-based study detected a lower overall nonpenetrance than previously observed, probably due to many asymptomatic mutation carriers identified by careful examination of facial and shoulder muscles. The recognition of asymptomatic mutation carriers is essential for selection of participants for future trials, and the likelihood estimates are helpful in counseling.
引用
- Wohlgemuth M, Lemmers RJ, Jonker M, et al. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1. Neurology. 2018. PMID: 29997197. doi:10.1212/WNL.0000000000005915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。